Key statistics
As of last trade, Uniqure NV (UQ1:STU) traded at 9.00, 24.10% above the 52 week low of 7.25 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.37 |
|---|---|
| High | 14.08 |
| Low | 7.37 |
| Bid | 8.94 |
| Offer | 8.99 |
| Previous close | 13.14 |
| Average volume | 704.44 |
|---|---|
| Shares outstanding | 62.29m |
| Free float | 58.86m |
| P/E (TTM) | -- |
| Market cap | 654.06m USD |
| EPS (TTM) | -4.39 USD |
Data delayed at least 15 minutes, as of Mar 02 2026.
More ▼
- uniQure Announces 2025 Financial Results and Provides Recent Company Updates
- uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
- uniQure to Announce 2025 Financial Results
- uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
- uniQure Announces Type A Meeting Scheduled with FDA
- uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
- uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
- uniQure to Announce Third Quarter 2025 Financial Results
- uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
- uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
More ▼
